RNA DIAGNOSTICS INC.

Rna Diagnostics is a clinical stage molecular diagnostics company leading a paradigm shift in early-stage cancer care. Their Veridapt DX predictive biomarker platform delivers timely, actionable insight into primary cancer treatment efficacy for solid tumors. Rna Diagnostics is a Canadian cancer diagnostics company. They are a clinical stage molecular diagnostics company for personalized cancer therapy management and have developed the RNA Disruption Assay, a molecular test performed at an early treatment time point, predicts with a very high degree of certainty whether a patient will or will not achieve a survival benefit from a chosen drug regimen.